{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:46:34Z","timestamp":1777927594008,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Nuclear interferon-inducible protein 16 (IFI16) and anti-IFI16 antibodies have been detected in subjects with several rheumatic diseases, often correlating with disease severity, and in this study we investigated their prevalence and clinical associations in psoriatic arthritis (PsA) compared to psoriasis (Pso). We tested sera and synovial fluids of patients with PsA for IFI16 protein levels by capture enzyme-linked immunosorbent assay (ELISA) and for anti-IFI16 immunoglobulin (Ig)G and IgA by ELISA, protein radio-immunoprecipitation and immunoprecipitation-Western blot of IgG. Sera from patients with Pso and healthy subjects were used as controls, and in a subgroup of patients with PsA we also studied sera after treatment with etanercept. IFI16 was detectable in the sera of 66% of patients with Pso, 46% with PsA and 19% of controls. Among PsA cases, 51% of IFI16-positive cases had elevated levels of C-reactive protein (CRP) compared to 31% of patients with undetectable IFI16. Anti-IFI16 of both IgG and IgA isoforms were detected with significantly higher frequency in PsA and Pso compared to healthy controls, with higher IgG titres in patients with elevated C-reactive protein (CRP) (P = 0\u00b7015). Immunoprecipitation confirmed the presence of anti-IFI16 IgG antibodies and these preferentially recognized epitopes outside the N-terminus of the protein. Lastly, IFI16 was detected in one of seven and anti-IFI16 in three of seven synovial fluids from patients with PsA. Therefore, IFI16 and anti-IFI16 are detectable in serum and synovial fluid of PsA patients, especially in cases of elevated CRP.<\/jats:p>","DOI":"10.1111\/cei.13376","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T05:56:12Z","timestamp":1569909372000},"page":"88-96","source":"Crossref","is-referenced-by-count":19,"title":["Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis"],"prefix":"10.1093","volume":"199","author":[{"given":"M","family":"De Andrea","sequence":"first","affiliation":[{"name":"Department of Public Health and Paediatric Sciences, Turin Medical School, Turin, Italy"},{"name":"Department of Translational Medicine, Novara Medical School, Novara, Italy"},{"name":"Intrinsic Immunity Unit, CAAD, Center for Translational Research on Autoimmune and Allergic Diseases, University of Piemonte Orientale, Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3196-1336","authenticated-orcid":false,"given":"M","family":"De Santis","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Caneparo","sequence":"additional","affiliation":[{"name":"Department of Public Health and Paediatric Sciences, Turin Medical School, Turin, Italy"},{"name":"Department of Translational Medicine, Novara Medical School, Novara, Italy"},{"name":"Intrinsic Immunity Unit, CAAD, Center for Translational Research on Autoimmune and Allergic Diseases, University of Piemonte Orientale, Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Generali","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Sirotti","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Isailovic","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Guidelli","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ceribelli","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Fabbroni","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Siena, Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Simpatico","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Siena, Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Cantarini","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Siena, Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Gisondi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Verona, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Idolazzi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Verona, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gariglio","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Novara Medical School, Novara, Italy"},{"name":"Intrinsic Immunity Unit, CAAD, Center for Translational Research on Autoimmune and Allergic Diseases, University of Piemonte Orientale, Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Selmi","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy"},{"name":"Humanitas University, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"2022021407184165500_cei13376-bib-0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2022021407184165500_cei13376-bib-0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2022021407184165500_cei13376-bib-0003","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.rdc.2015.07.006","article-title":"Etiology and pathogenesis of psoriatic arthritis","volume":"41","author":"Barnas","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2022021407184165500_cei13376-bib-0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13317-013-0057-4","article-title":"The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications","volume":"5","author":"Marinoni","year":"2014","journal-title":"Auto Immun Highlights"},{"key":"2022021407184165500_cei13376-bib-0005","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2022021407184165500_cei13376-bib-0006","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.rdc.2015.07.013","article-title":"Etiology and pathogenesis of psoriasis","volume":"41","author":"Boehncke","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2022021407184165500_cei13376-bib-0007","doi-asserted-by":"crossref","first-page":"e2737","DOI":"10.1371\/journal.pone.0002737","article-title":"Type I interferon: potential therapeutic target for psoriasis?","volume":"3","author":"Yao","year":"2008","journal-title":"PLOS ONE"},{"key":"2022021407184165500_cei13376-bib-0008","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaad.2009.05.042","article-title":"A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis","volume":"62","author":"Bissonnette","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2022021407184165500_cei13376-bib-0009","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaci.2014.05.046","article-title":"Humanized anti-IFN-gamma (HuZAF) in the treatment of psoriasis","volume":"135","author":"Harden","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2022021407184165500_cei13376-bib-0010","first-page":"5","article-title":"The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response","volume":"38","author":"Dell\u2019Oste","year":"2015","journal-title":"New Microbiol"},{"key":"2022021407184165500_cei13376-bib-0011","doi-asserted-by":"crossref","first-page":"33515","DOI":"10.1074\/jbc.M701846200","article-title":"A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells","volume":"282","author":"Caposio","year":"2007","journal-title":"J Biol Chem"},{"key":"2022021407184165500_cei13376-bib-0012","doi-asserted-by":"crossref","first-page":"22745","DOI":"10.1038\/srep22745","article-title":"NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis","volume":"6","author":"Tervaniemi","year":"2016","journal-title":"Sci Rep"},{"key":"2022021407184165500_cei13376-bib-0013","doi-asserted-by":"crossref","first-page":"e0128262","DOI":"10.1371\/journal.pone.0128262","article-title":"Gene expression profiling in peripheral blood cells and synovial membranes of patients with psoriatic arthritis","volume":"10","author":"Dolcino","year":"2015","journal-title":"PLOS ONE"},{"key":"2022021407184165500_cei13376-bib-0014","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.38995","article-title":"Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis","volume":"67","author":"Belasco","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2022021407184165500_cei13376-bib-0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0961203313484978","article-title":"Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus","volume":"22","author":"Caneparo","year":"2013","journal-title":"Lupus"},{"key":"2022021407184165500_cei13376-bib-0016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13075-015-0722-2","article-title":"Interferon gamma-inducible protein 16 in primary Sjogren's syndrome: a novel player in disease pathogenesis?","volume":"17","author":"Alunno","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2022021407184165500_cei13376-bib-0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/acr.22632","article-title":"Association of antibodies to interferon-inducible protein-16 with markers of more severe disease in primary Sjogren\u2019s syndrome","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022021407184165500_cei13376-bib-0018","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/art.22266","article-title":"A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16","volume":"54","author":"Mondini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2022021407184165500_cei13376-bib-0019","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/rheumatology\/keq372","article-title":"Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis","volume":"50","author":"Costa","year":"2011","journal-title":"Rheumatology (Oxf)"},{"key":"2022021407184165500_cei13376-bib-0020","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.39558","article-title":"Anti-interferon-inducible protein 16 antibodies associate with digital gangrene in patients with scleroderma","volume":"68","author":"McMahan","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022021407184165500_cei13376-bib-0021","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1097\/MIB.0000000000000926","article-title":"Distinct anti-IFI16 and anti-GP2 antibodies in inflammatory bowel disease and their variation with infliximab therapy","volume":"22","author":"Caneparo","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2022021407184165500_cei13376-bib-0022","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/acr.22695","article-title":"Circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis","volume":"68","author":"Alunno","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022021407184165500_cei13376-bib-0023","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2022021407184165500_cei13376-bib-0024","doi-asserted-by":"crossref","first-page":"e63045","DOI":"10.1371\/journal.pone.0063045","article-title":"Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding","volume":"8","author":"Gugliesi","year":"2013","journal-title":"PLOS ONE"},{"key":"2022021407184165500_cei13376-bib-0025","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2022021407184165500_cei13376-bib-0026","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10067-016-3453-0","article-title":"Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis","volume":"36","author":"Ceribelli","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2022021407184165500_cei13376-bib-0027","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/art.22329","article-title":"Autoantibodies to RNA helicase A: a new serologic marker of early lupus","volume":"56","author":"Yamasaki","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022021407184165500_cei13376-bib-0028","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"2022021407184165500_cei13376-bib-0029","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun"},{"key":"2022021407184165500_cei13376-bib-0030","article-title":"Clinical features of psoriatic arthritis: a comprehensive review of unmet clinical needs","author":"McArdle","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2022021407184165500_cei13376-bib-0031","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gendis.2014.10.003","article-title":"The roles of interferon-inducible p200 family members IFI16 and p204 in innate immune responses, cell differentiation and proliferation","volume":"2","author":"Zhao","year":"2015","journal-title":"Genes Dis"},{"key":"2022021407184165500_cei13376-bib-0032","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.4049\/jimmunol.1302120","article-title":"Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA","volume":"192","author":"Chiliveru","year":"2014","journal-title":"J Immunol"},{"key":"2022021407184165500_cei13376-bib-0033","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/jir.2014.0168","article-title":"The extracellular IFI16 protein propagates inflammation in endothelial cells via p38 MAPK and NF-kappaB p65 activation","volume":"35","author":"Bawadekar","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"2022021407184165500_cei13376-bib-0034","doi-asserted-by":"crossref","first-page":"102299","DOI":"10.1016\/j.jaut.2019.06.010","article-title":"Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review","author":"Shin","year":"2019","journal-title":"J Autoimmun"},{"key":"2022021407184165500_cei13376-bib-0035","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","article-title":"Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review","volume":"16","author":"Lee","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2022021407184165500_cei13376-bib-0036","first-page":"21","article-title":"The importance of the type I interferon system in autoimmunity","volume":"34","author":"Ronnblom","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2022021407184165500_cei13376-bib-0037","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2133.2010.10097.x","article-title":"Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing","volume":"164","author":"Costa","year":"2011","journal-title":"Br J Dermatol"},{"key":"2022021407184165500_cei13376-bib-0038","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.1038\/srep25381","article-title":"Up-regulation of Interferon-inducible protein 16 contributes to psoriasis by modulating chemokine production in keratinocytes","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13376","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13376","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13376","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/199\/1\/88\/42507688\/cei13376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/199\/1\/88\/42507688\/cei13376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T03:30:21Z","timestamp":1695267021000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/199\/1\/88\/6402748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,10,15]]},"published-print":{"date-parts":[[2019,12,10]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13376","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,10,15]]}}}